title: Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis.
abstract: Spontaneous bacterial peritonitis (SBP) is a severe complication in patients with cirrhosis and ascites. It is predominantly caused by Escherichia coli. The phylogenetic group and virulence genotype of E. coli isolates causing SBP were investigated, and the association of these characteristics with host factors and prognosis was examined. Seventy-six episodes of E. coli SBP that occurred over a 9-year period were studied. The phylogenetic group of the isolates and the presence of 36 virulence factor genes were investigated. The influence of bacterial and host factors on in-hospital mortality was assessed by multiple logistic regression. Phylogenetic groups A, B1, B2 and D were found in 26%, 4%, 46% and 24% of the isolates, respectively. Virulence factor genes were more frequent in B2 isolates than in non-B2 isolates (mean virulence score 15.4 vs. 7.3, p <10(-4)). Ciprofloxacin resistance was significantly associated with non-B2 groups and a low virulence score. Host factors independently associated with a shift from B2 to non-B2 isolates were norfloxacin prophylaxis (OR 13.01, p 0.0213) and prothrombin ratio (OR 1.04 for a 10% decrease, p 0.0211). The model for end-stage liver disease (MELD) score (OR 1.83, p 0.0007) and hospital-acquired SBP (OR 4.13, p 0.0247) were independent predictors of in-hospital mortality. In contrast, outcome was not influenced by the phylogenetic group or the virulence profile. These findings indicate that the characteristics of E. coli isolates causing SBP vary with the severity of liver disease and with fluoroquinolone prophylaxis. Host factors are more important than bacterial factors in predicting in-hospital mortality.
authors.affiliation: Service de Microbiologie, Hôpital AP-HP Beaujon, Clichy, France. frederic.bert@bjn.aphp.fr
authors.forename: F
authors.initials: F
authors.lastname: Bert
authors.forename: X
authors.initials: X
authors.lastname: Panhard
authors.forename: J
authors.initials: J
authors.lastname: Johnson
authors.forename: H
authors.initials: H
authors.lastname: Lecuyer
authors.forename: R
authors.initials: R
authors.lastname: Moreau
authors.forename: J
authors.initials: J
authors.lastname: Le Grand
authors.forename: B
authors.initials: B
authors.lastname: Johnston
authors.forename: M
authors.initials: M
authors.lastname: Sinègre
authors.forename: D
authors.initials: D
authors.lastname: Valla
authors.forename: M-H
authors.initials: MH
authors.lastname: Nicolas-Chanoine
mesh_terms: D000328:Adult; D000368:Aged; D001201:Ascites / Q000150:complications; D004269:DNA, Bacterial / Q000235:genetics; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification* / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000382:microbiology* / Q000401:mortality; D029968:Escherichia coli Proteins / Q000235:genetics*; D005260:Female; D005355:Fibrosis / Q000150:complications; D005838:Genotype; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010538:Peritonitis / Q000382:microbiology* / Q000401:mortality; D011379:Prognosis; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics*
chemical_list: D004269:DNA, Bacterial; D029968:Escherichia coli Proteins; D037521:Virulence Factors